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THE PURPOSE OF this study was to assess tissue changes responsible for dural enhancement on magnetic resonance 
imaging (MRI) and its clinical implications. A prospective surgical, histopathological, and MRI study was performed 
in 73 patients with various types of disease, including meningiomas (n =  29), craniofacial tumors with possible direct 
intracranial extension (n =  21), gliomas and brain metastasis in close proximity to the dura mater (n =  9), and a variety 
of nonneoplastic processes (n =  14). Contrast-enhanced MRI was obtained within 5 days before surgery and in some 
cases within 3 days after surgery as well. Histopathological examination of the dural specimens was performed in all 
59 patients with neoplasia and in selected patients with nonneoplastic processes. Dural invasion was noted in 18 of 
29 meningiomas, 15 of 21 craniofacial neoplasms, 3 of 5 gliomas, and 3 of 4 brain metastases. In these patients invasion 
was focal and in direct continuity with the tumors. MRI disclosed that dura invaded by the tumor had a break in the 
continuity of enhancement, or that there was no discernible enhancement. Association between patterns of dural 
enhancement and tumor invasion of dura was statistically significant (P < 0.001). The thickened-enhanced portion 
of the dura represented reactive changes. Postoperative enhancement was seen as early as 24 hours after surgery and 
was shown histologically to be associated with vasodilation and reactive changes. Conclusions from this study are:
1) dural enhancement is a nonspecific reaction and may be seen in association with many pathological conditions;
2) a fairly uniform "enhanced dura" adjacent to a tumor correlated with a dural inflammatory reaction, whereas 
discontinuous enhancing dura indicated dural invasion; 3) a few false-negative cases of dural invasion (one extracra- 
nial and four intracranial neoplasms) underscore that there are some limitations of contrast-enhanced MRI in 
predicting dural invasion by adjacent neoplasms. (Neurosurgery 35:370-377, 1994)
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Controversy exists as to whether a "thickened-enhanced These patients were diagnosed from a total of approximatelydura" adjacent to an intracranial neoplasm represents 4000 contrast-enhanced magnetic resonance (MR) images of
inflammation (2, 21) or invasion of dura (8, 25). Cor- brain performed during a 3-year period ending September
rectly recognizing dural invasion from that of reactive changes 1993. Fifty-nine consecutive patients with neoplasia, who un-
has important surgical implications, in that a decision must be derwent surgery, consisted of 21 with craniofacial and calvarial
made whether to resect (along with tumor itself) the "enhanced neoplasms with possible intracranial extensions, 29 with in-
dura that is contiguous with the neoplasm to prevent or tracranial meningiomas, and with 9 gliomas and metastases in
reduce local recurrence (5, 9,13,16). To address this issue, we close proximity to the dura mater. We also included 14 patients
have prospectively studied three groups of patients that in- wj th dural enhancement caused by nonneoplastic processes,
eluded a wide range of diseases. These nontumor cases were selected at random. In this group
of patients, there was no evidence of associated acute or
PATIENTS AND METHODS chronic meningitis, either by MR imaging (MRI) or analysis of
We prospectively studied a total of 73 newly diagnosed cerebrospinal fluids,
adult patients 29 to 81 years of age with possible abnormal Seventy-one patients were imaged with 1.5-T MR imagers
dural enhancement from a wide variety of causes (Table 1). (SI5 HP, Phillips Medical Systems North America, Shelton, CT,
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TABLE 1. Patients (n =  73)
Craniofacial/calvarial neoplasms3 21
Squamous cell carcinoma 5
Nasopharyngeal carcinoma 4














Superior saggital thrombosis 1
Lymphocytic adenohypophysitis 2
Chronic subdural hematoma 1
Epidural empyema 1
a Some of these patients have been previously reported (1).
TABLE 2. Histological Diagnosis in 59 Cases of Neoplasms
Assessed for Dural-Arachnoid Invasion
, No. of Cases of
Type of Tumor Case5 Dural Invasion
Craniofacial
Scalp squamous carcinoma 5 3
Nasopharyngeal carcinoma 4 2
Sinonasal sarcomas or carcinoma 3 2
Esthesioneuroblastoma 2 2
Calvarial meningiomas 3 3
Intrasphenoid craniopharyngioma 1 1
Hemangiopericytoma 1 0





or Signa Advantage, General Electric Medical Systems, Mil­
waukee, WI) and two patients with a 0.5-T MR im ager (Vista, 
Picker International, Highland Heights, OH). Contrast- 
enhanced Tl-weighted im ages (in addition to conventional 
noncontrast-enhanced spin-echo sequences) were obtained in 
two or three planes and within 5 days before surgery in all 73 
patients included in this study. In addition, in four patients 
who had minor intracranial procedures through burr holes, 
additional postoperative MR studies were done within 3 days 
after surgery. Sections of 3- to 5-mm thickness and 1-mm 
intersection gaps were acquired within 2 to 18 minutes after 
intravenous administration of 0.1 m m ol/kg of gadopentetate 
dimeglumine (Magnevist, Berlex Imaging, Wayne, NJ), using 
repetition times of 600 to 750 msec, echo times of 16 to 20 msec, 
two signal averages, and a 256 X 204 matrix.
TABLE 3. Correlation of Magnetic Resonance Imaging and 
Histological Examination of Dura-Arachnoid Adjacent to 
Neoplasms (n =  59)a
Magnetic Resonance Findings Type of Tumor
Histology of Dura
Invaded , Invaded













a Association between tumor invasion and the patterns of dural- 
enhancement is statistically significant (x2 = 46.00, df= 2, P <  0.001), 
whereas the association between tumor invasion and dural enhance­
ment is not { \ 2 = 5.682, df =  2, P = 0.058).
FIGURE t. Sinonasal carcinoma with reactive changes in the 
dura. A sagittal postcontrast Tt-weighted MR image shows a 
long strip of fairly uniform enhancing dura (arrows) with 
no break in the continuity of the enhancing dural band. The 
neoplasm was abutting the dura ( curved arrow) but not 
invading it.
Histopathological examination of dura in all 59 patients with 
neoplasm s and in selected patients with nonneoplastic pro­
cesses w as performed. In 12 patients with neoplasia, the tu­
m ors and large segments of dura (3-5 cm beyond the tumor 
extends) were resected en-bloc, and thorough histological ex­
aminations of the surgical specimens were performed. In the 
other 47 patients with neoplasia, multiple dural biopsies were 
obtained for histopathological examination. For statistical 
analysis of data the x2 test (SigmaStat program , Jandel Scien­
tific, San Rafael, CA) w as used, and P < 0.05 was considered 
significant.
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RESULTS
Contrast-enhanced MR im ages were evaluated for possible 
morphological changes along dura-arachnoid membranes in a 
wide variety of pathological processes. They included 59 pa­
tients with neoplasia and 14 patients with nonneoplastic pro­
cesses. Prominent dural enhancement is defined as a linear 
strip of enhancing tissue along the dura mater originating from 
an d /or extending outward from the tumor margin that is 
observed in at least two different imaging planes.
Neoplasm
From a total of 59 patients with neoplasia assessed for pos­
sible dural invasion (Table 2), dural enhancement w as ob­
served adjacent to and beyond the tumors in 46 patients, and 
no enhancement of the dura-arachnoids w as visualized in 13
patients. Two patterns of abnormal dural-arachnoid enhance­
ment (continuous and discontinuous) were identified (Table 3). 
In 12 patients, the dura w as enhanced in continuity and was 
fairly uniform in thickness. Histopathological examination of 
the dura-arachnoids revealed only reactive changes without 
neoplastic invasion (Fig. 1 ). In the other 34 patients with ab­
normal dural enhancement, there were either areas where the 
enhancement of the tumors could not be separated from that 
of the dura or where the enhancing dura appeared discon­
tinuous (Figs. 2 and 3). The dura mater in these 34 patients was 
focally invaded by the adjacent neoplasm. Histopathological 
examination of the dura from these patients confirmed that the 
dural invasion corresponded either to a discontinuous seg­
ment of the enhancing dura or to the area where the dura could 
not be distinguished from the adjacent enhancing tumor. Sta-
t r .
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FIGURE 2. Convexity meningioma with focal dural invasion. A, postcontrast coronal T1 -weighted MR image revealed a thick­
ened enhanced strip of tissue adjacent to and emanating from the meningioma (arrow). Medially, a segment of the dura is, 
however, indistinguishable from the enhancing meningioma that abuts the inner table of the calvarium (curved arrow).
B and C, photomicrographs (hematoxylin and eosin) of a sample (at the site where the dura was not distinguishable from the 
meningioma) shows an aggressive meningioma with a high proliferation rate and zones of focal necrosis. The tumor shows 
focal invasion (arrow) into the dura, seen at lower original magnification in B (X25) and at higher original magnification in 
C (xlOO). Note the lack of associated inflammation in the dura. The thickness of the dura is shown by the double-headed ar­
rows; the infiltrating tumor in the dura is indicated by an arrowhead. D, Photomicrograph of the thickened enhancing tissue 
emanating from the meningioma (solid straight arrow  in Fig. 4A ) shows hypervascularization and arachnoidal proliferation 
but no tumor invasion (hematoxylin and eosin, original magnification X25).
:e
<r- . - %
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FIGURE 3. Frontal basal squamous carcinoma. A, axial postcontrast T1-weighted MR image shows that part of the dura in 
the left side is indistinguishable from the adjacent enhancing neoplasm (straight arrows). This part of the dura was invaded 
by the adjacent tumor (see B). A thickened enhancing strip of tissue is seen extending far away from the tumor along the 
dura in the opposite hemisphere (curved arrows). Histological examination of the latter dural sample revealed only reactive 
changes (see C). B, photomicrograph (hematoxylin and eosin, original magnification X25) of dural specimen (at the site 
where the dura was indistinguishable from the adjacent neoplasm) demonstrates extensive dural invasion (arrows).
C, photomicrograph of a specimen obtained from an enhancing strip of tissue along the dura (at the site of the curved arrows 
in A) shows arachnoidal proliferation (arrows) and mild chronic inflammation. No neoplastic cells were identified in this 
segment (hematoxylin and eosin, original magnification x350). This meningothelial proliferation can, however, be easily 
distinguished from basal-squamous cell carcinoma in this case.
| FIGURE 4. Metastatic adenocarcinoma with dural invasion. Coronal (A) and axial (B) postcontrast T1-weighted MR images
l show no distinguishable dural enhancement adjacent to or emanating from the tumor. C, photomicrograph (hematoxylin and
I eosin, original magnification X40) of dural specimen adjacent to neoplasm showing the presence of metastatic adenocarci-
| noma, with its stroma adherent to the undersurface and infiltrating into the dura (arrows). The extent of the dural thickness
1 's indicated by a double-headed arrow, and the infiltrating neoplasm is shown by an arrowhead.
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tistical analysis of the data revealed that the patterns of dural 
enhancement were significantly associated with dural invasion 
by tumor (P < 0.001), whereas the association between tumor 
invasion of dura and merely presence or absence of dural 
enhancement was not statistically significant (P, 0.058).
In the remaining 13 patients contrast-enhanced MRI did not 
reveal any dural abnormalities, either prospectively or retro­
spectively. Histopathological examination of the dura, how­
ever, demonstrated dural invasion by the adjacent tumor in 5 
(Fig. 4) and no dural invasion in 8 of these patients. His­
topathological examination of the dura from these 13 patients 
(with no dural enhancement) also revealed minimal or no 
reactive changes.
Thirty-five of our patients with neoplasia underwent fol­
low-up contrast-enhanced MRI. Thickened-enhanced dura- 
arachnoids were observed on all postoperative MRI scans, 
which were more extensive (compared with preoperative MRI 0  
scans) and covered much larger areas of the dura far beyond ' 
the sites of the craniotomies. Histopathological reexamination 
of postoperative dura was obtained in five patients who had 
second operations. Examination of the dura within 2 to 3 cm -■ -r 
at the edges of the first operations showed marked reactive * 
dural-arachnoid changes with no evidence of recurrence of ■ 
tumors at the sites of the initial tumors (Fig. 5).
- H r
Nonneoplastic processes
Abnormal dural enhancement was observed in four pa­
tients, 1 to 3 days after minor surgical procedures such as shunt 
placements or computed tomography-guided stereotactic cyst 
punctures (Fig. 6). Histopathological examination revealed an 
acute inflammation of the dura. Dural enhancement was noted 
in the following cases: 1) in association with a single dural- 
based sarcoid lesion in two patients (Fig. 7); 2) adjacent to 
intracerebral granulomatous infections in three patients; 3) in 
association with thrombosis of the superior sagittal sinuses in 
one patient; 4) in association with lymphocytic adenohy-
FIGURE 6. Acute postoperative inflammation of the dura.
A, preoperative contrast-enhanced MR image shows a right 
ventricular epithelial cyst without dural enhancement (not 
shown). Computed tomography-guided stereotactic puncture 
of the cyst through a right parietal burr hole was unsuccess­
ful. A contrast-enhanced MR image obtained 36 hours later 
shows dural enhancement (arrows). B, photomicrograph 
(hematoxylin and eosin, original magnification x100) of du­
ral samples obtained the next day at the time of craniotomy 
reveals presence of polymorphonuclear cells around small 
vessels extending into the adjacent connective tissue 
(arrows).
pophysitis in two patients; 5) in association with chronic sub­
dural hematoma in one patient; and 6) in association with 
epidural empyema in one patient. In these groups of patients, 
there was no evidence of associated acute or chronic meningitis 
either by MRI or analysis of cerebrospinal fluids.
FIGURE 5. Biopsy of chronic postoperative enhancing tissue 
along the dura-arachnoid shows reactive changes consisting 
of chronic inflammation and neovascularization, which 
predominately involves the arachnoid membrane. There are 
no tumor cells present.
DISCUSSION
With the exception of the falx and tentorium, normal dura 
mater is invisible on routine contrast-enhanced T1-weighted 
spin-echo images. Enhancement of falx cerebri and tentorium, 
however, has been observed in 50% of healthy subjects using 
thin-section MRI (3, 10). A wide variety of pathological con­
ditions may render dura visible on contrast-enhanced MRI (1,
Neurosurgery, Vol. 35, No. 3, September 1994
MR-enhanced Dura 375
FIGURE 7. High-convexity single dural-based sarcoid lesion. A, precontrast coronal MR image shows a dural-based extraaxial 
soft tissue mass (curved arrow). B, postcontrast coronal MR image shows enhancement of the sarcoid plaque. In addition, 
there is a dense thickened enhancing dura-arachnoid seen emanating from the sarcoid plaque and extending over the convex­
ity, as well as into interhemispheric fissure (straight arrows). C, photomicrograph of the subdural mass (curved arrows in 
A and B) shows the presence of numerous noncaseating sarcoid granulations septated by connective tissue septa (hematoxylin 
and eosin, original magnification xIO ). D, photomicrograph of thickened enhancing dura-arachnoid membranes (straight 
arrows in A and B) shows arachnoidal proliferation (arrowhead) without involvement by the sarcoid (original magnification 
X 40).
2, 6, 8, 19, 21, 23-25). Any or all three membranes of the 
meninges (dura mater, arachnoid, and pia mater) may be af­
fected. Absence of abnormal enhancement on MRI within the 
depth of the sulci and cisterna helps differentiate dural from 
pial involvement (1,6,19). It is important to emphasize that the 
so-called thickened-enhanced dura (8) is not merely limited to 
dura mater alone. Histopathological examination of our ma­
terial revealed that tissue changes responsible for an enhanced 
band on MRI along the dura mater is composed of prolifera­
tion, inflammation, and hypervascularity, which predomi­
nately involves the arachnoid membrane rather than dura ma­
ter itself. Therefore, for practical purposes in interpretation of 
MRI, dura/arachnoid may be considered as one unit as op­
posed to pia/subarachnoid space. Diffuse meningeal enhance­
ment after craniotomy is well known and has been regarded 
as a reactive change secondary to interruption of the dura (6, 
12,13). Reactive changes can occur acutely within a few days
after even minor surgical procedures. Inclusion of several other 
examples of nonneoplastic pathological conditions in this 
study further underscores the fact that dural enhancement is 
a nonspecific reaction.
Neoplastic diseases can involve dura by several mecha­
nisms: 1) craniofacial and calvarial neoplasms may grow in­
tracranially and invade the dura directly; the tumor then may 
progress further inward, with possible brain parenchymal in­
volvement (1,15); 2) extracranial neoplasms may extend along 
foramina and fissures at the cranial base and involve the ad­
jacent dura (7,11,13,17,20,22, 23); 3) meningiomas originate 
from arachnoid cells and may then invade brain parenchyma, 
dura, or both (4,5,14,15,18); 4) a primary or metastatic brain 
neoplasm in close proximity to the surface can invade the 
adjacent dura (15, 25); and 5) a neoplasm may spread into the 
meninges (e.g., meningeal carcinomatosis) via a hematogenous 
route (19). The invasion of dura by a neoplasm is initially focal.
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The invading neoplastic tissue may partially or totally replace 
the dural thickness. The invaded segment of dura may then 
enhance like the rest of the tumor. Thus, the invaded portion(s) 
of dura may become indistinguishable from the invading neo­
plasm (1). At the same time, the noninvaded segment of the 
dura may become thickened by secondary reactive vascular 
tissue and may display enhancement after administration of 
contrast material. Therefore, a dura that is invaded focally and 
is also associated with secondary reactive changes demon­
strates a discontinuous pattern of dural enhancement (34 pa­
tients in this report). In contrast, in 12 of the patients in the 
present study in whom the dura adjacent to the tumors were 
not invaded at all, but there was histopathological evidence of 
inflammatory changes, the enhancing dura was continuous. In 
13 of our patients the dura adjacent to neoplasms (whether the 
dura was invaded) did not enhance at all after the adminis­
tration of contrast material. Interestingly, in these 13 patients 
there was minimal or no histopathological evidence of asso­
ciated reactive changes in the dura mater. However, 5 of these 
13 patients with nonenhancing dura had histopathological evi­
dence of dural invasion. Patterns of dural enhancement in 
relationship to tumor invasion of dura was statistically sig­
nificant. However, the presence or absence of dural enhance­
ment in association with tumor invasion of dura was not sta­
tistically significant. These 5 false-negative cases illustrate 
potential limitations of the use of contrast-enhanced MRI. It 
had been pointed out in the past that dural enhancement 
adjacent to intracranial tumors need not imply neoplastic 
spread (2, 21). Tokumaro et al. (21) correlated MRI and his­
tological examination of dura adjacent to four cases of con­
vexity meningiomas. They have shown that the thickened en­
hancing dura associated with these meningiomas were caused 
by hypervascularity and proliferation of connective tissue 
without histopathological evidence of dural invasion by the 
tumors. Histopathological examination of postoperative dura 
in five patients in this study, who had second surgery for 
tumors at other sites, showed marked reactive dural-arachnoid 
changes with no evidence of recurrence of tumors at the sites 
of the initial tumors. Borovich and Doron have documented 
meningothelial cell aggregates in strips of dura far away from 
a solitary meningioma. They pointed out that the intradural 
location of these clusters and their independence from blood 
vessels negate seedings and dural metastases. The authors 
concluded that regional multicentricity of meningothelial clus­
ters plays an important role in recurrence of intracranial men­
ingiomas (4). Dural enhancement adjacent to calvarial metas- 
tases also have been described previously. However, because 
dural biopsy was not performed, the authors could not deter­
mine whether this dural enhancement was caused by menin­
geal tumor spread or by benign dural reaction (23).
Based on this study, if the dura adjacent to a neoplasm is seen 
as a fairly uniform enhancing band on contrast-enhanced MRI, 
this dura is most likely reactive and not invaded by the tumor. 
Conversely, the presence of areas of dura indistinguishable 
from the adjacent tumor, or a focal break in the continuity of 
enhancing dura adjacent to a neoplasm, is a likely indication 
of focal dural invasion by the tumor and thus warrants its 
resection along with the tumor.
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COMMENTS
This is a most interesting report by Ahmadi and colleagues 
on the diagnostic implications of dural enhancement when 
seen on preoperative and postoperative magnetic resonance 
imaging scans. The pattern of enhancement (i.e., continuous 
versus discontinuous) seems to be of greater import than its 
mere presence (Table 3). Discontinuous enhancement is asso­
ciated with neoplastic invasion (P < 0.001), but the latter can 
occur in the absence of enhancement. These statistical conclu­
sions are supported by the available histological material (Figs. 
4 and 5).
Of further interest is the finding that meningeal enhance­
ment in patients with brain tumors is apparently uncommon; 
59 cases were seen during a 3-year period in which more than 
4000 scans were performed. Unfortunately, we are not told the 
total number of patients with brain tumors who were scanned 
and who did not have meningeal enhancement. Additionally, 
because the presence of postoperative enhancement is espe­
cially confusing to the clinician and potentially ominous for the 
patient, it would have been important for the authors to make 
direct comparisons of the preoperative and postoperative 
scans for individual cases in which histologic analyses were 
also available. Does preoperative enhancement predict post­
operative change? Is the incidence of dural invasion increased 
by surgery? These are just some of the many questions that 
remain unanswered by this fine contribution.
Michael Salcman
Baltimore, Maryland
This paper helps us understand better the phenomenon of 
dural enhancement seen so often in association with neoplasia 
near the dura.
Ahmadi et al. have nicely demonstrated here that dural 
enhancement with gadolinium is a nonspecific finding with 
brain tumors. They suggest but do not prove conclusively that 
"discontinuous enhancement" is a result of tumor, but other 
enhancement may be inflammation or neoplastic. It is an im­
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